Skip to main content

Journals in Immunopathogenesis

Focusing on the mechanisms underlying immune-related diseases, this portfolio explores autoimmunity, hypersensitivity, and immune dysregulation. It benefits researchers, clinicians, and students seeking to understand disease development at the immune level. Featuring case studies, molecular insights, and therapeutic approaches, these resources support the advancement of targeted treatments and personalized medicine strategies in immune-mediated disorders.

  • Molecular and Biochemical Parasitology

    • ISSN: 0166-6851
    Molecular and Biochemical Parasitology provides a medium for rapid publication of investigations of the molecular biology and biochemistry of parasitic protozoa, fungi, helminths and ectoparasites, including molecular interactions between parasites and their definitive and intermediate hosts and their vectors.  This includes emerging or neglected eukaryotic pathogens.The main subject areas covered are:• The structure, biosynthesis, degradation, properties and function of parasite biomolecules - DNA, RNA, proteins, lipids, carbohydrates and small molecular-weight substances. This includes molecules of intermediary metabolism and bioenergetics. host-parasite relationships particularly as related to specific parasite molecules. • The response of host organisms to infection, and the response of host cells to intracellular parasites.  Included are studies on the detailed molecular mechanisms of anti-parasitic immune responses, parasite immune evasion, and host-pathogen signalling pathways.• “Omics” technologies and systems biology, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics of parasites and the host’s response to infection.• Vector-parasite relationships at the molecular level; this includes molecular studies on arthropod vectors that transmit parasites, especially those focusing on vector-parasite interactions, vector immunity, and vector control strategies.• Structural studies of parasite proteins and their interactions. • Drug target characterization and the mode of action of antiparasitic drugs; mechanisms of drug resistance; novel therapeutics including natural products, synthetic compounds, and vaccine candidates.  Please note that studies that are restricted to in silico docking of compounds or other purely computational approaches will not be accepted in the absence of some experimental validation.• Analysis of variation in parasite populations relevant to genetic exchange, pathogenesis, drug and vaccine target characterization, and drug resistance; please note that genetic variation data must be supported by phenotypic/experimen... data showing the effect of the variation, and that papers reporting solely on allele frequencies in specific regions will not be accepted.• Parasite protein trafficking, organelle and membrane biogenesis, and cellular structure especially with reference to the roles of specific molecules• Parasite programmed cell death, development, and cell division at the molecular level• Parasitic disease diagnostics, especially molecular diagnostics, biomarkers, and biosensors for parasite detection and disease monitoring.•Microbiomes of parasites, symbiotic relationships, and how microbiota influence parasite development and pathogenicity.• Environmental molecular parasitology, including studies linking molecular parasitology with ecological and environmental factors influencing parasite transmission, adaptation, and evolution.• Methods reports - descriptions of novel or newly-optimized methods with broad applicability to molecular and biochemical parasitologyPapers will only be accepted for publication if they fall within these areas, if they contain original and complete work of high scientific quality, and if they are well presented and clearly written in scientific English. Papers solely confirming the conserved functions of genes previously studied in other organisms will not be considered. We welcome short communications documenting a succinct but clear and important advance.
  • Vaccine

    • ISSN: 0264-410X
    The official journal of The Japanese Society for Vaccinology.Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas (such as passive immunization) are welcomed. Vaccine publishes primary Research Papers, Review Articles, Short Communications, Conference Reports and Letters on the following topics:History of VaccinologyHuman Fungal/Parasite/Othe... VaccinesHuman Non-Infectious Disease Vaccines (cancer, allergy, other)Human Viral Vaccines: Basic ResearchNovel Pathogen Vaccines (Biodefense/High Consequence Pathogens/Emerging Diseases)Vaccine Acceptance/Hesitancy... Basic Science (Immunology/Animal Models)Vaccine EthicsVaccine Manufacturing and BioprocessingVaccine Operational Research (Evaluation/Epidemio... /BigData and Analytics)Vaccine Policy Legislation/Economic... Health)Vaccine Regulatory Science (Implementation/Guid... Health)Vaccine Safety ScienceVaccine Technology (Vectors/Adjuvants/D... Systems/Nanotechnolo... Bacterial VaccinesVeterinary Fungal/Parasite/Othe... VaccinesVeterinary Viral VaccinesVisual Vaccinology Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions. We also invite authors to submit relevant basic science and clinical reviews, methodological articles, opinion and commentary pieces, visual pieces, and letters. Vaccine has an open access companion journal titled Vaccine: X.
  • Immunology Letters

    • ISSN: 0165-2478
    Published by Elsevier as the official journal of the European Federation of Immunological Societies (EFIS), a member of the International Union of Immunological SocietiesImmunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular, cellular, and clinical immunology. As the official journal of the European Federation of Immunological Societies (EFIS), Immunology Letters supports international consortia of experts. The journal welcomes collaborative contributions dedicated to the state-of-the-art of immunology topics, as well as commentaries on those topics.Preference is given to papers of immediate importance to other investigators. Therefore, the essential criteria for publication are clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas are considered for publication provided they are based on solid experimental findings. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.
  • European Journal of Cancer

    • ISSN: 0959-8049
    Official Journal of EORTC and EUSOMAThe European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care.  Within its digital oncology scope, the journal welcomes high-quality studies on artificial intelligence, machine learning, computational imaging and pathology, digital biomarkers, real-world data, electronic health record-based research, digital therapeutics, clinical decision support, large language models and other digital health applications relevant to cancer prevention, diagnosis, treatment, survivorship and patient care. The journal prioritises digital and AI studies that are clinically grounded, methodologically robust, transparently reported, appropriately validated, and that consider generalisability, reproducibility, patient safety, privacy, equity and potential sources of bias.  The journal publishes original research, reviews, previews, editorial comments and correspondence.The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA).
  • Clinical Immunology

    • ISSN: 1521-6616
    Clinical Immunology publishes original research on the molecular and cellular bases of immunological disease. The journal also features reviews of timely topics in basic immunology, case reports, and letters to the editor.Research Areas Include:Ageing Allergy Autoimmunity Biotechnology Clinical Laboratory Immunology HIV Immunodermatology Immunohematology Immunotoxicology/Env... Infection and Immunity Mucosal Immunity Neuroimmunology Primary Immunodeficiency Transplantation Tumor Immunology Vaccines
  • Parasitology International

    • ISSN: 1383-5769
    The Official, International Journal of the Japanese Society of ParasitologyParasito... International provides a medium for rapid, carefully reviewed publications in the field of human and animal parasitology. Original papers, rapid communications, and original case reports from all geographical areas and covering all parasitological disciplines, including structure, immunology, cell biology, biochemistry, molecular biology, and systematics, may be submitted. Reviews on recent developments are invited regularly, but suggestions in this respect are welcome. Letters to the Editor commenting on any aspect of the Journal are also welcome.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
  • Seminars in Immunology

    • ISSN: 1044-5323
    Review articles in Seminars in Immunology are by invitation only.Seminars in Immunology is a review journal dedicated to keeping scientists informed of developments in the field of immunology on a topic by topic basis. Each issue is thematic in approach, devoted to an important topic of interest to immunologists, focusing on recent advances across a broad spectrum of research, from the molecular and cellular basis of the immune response to the possibilities for its manipulation. Every issue is edited by a guest editor, an internationally acknowledged expert in the field, and contains six to eight authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency. Topics Covered in Earlier Issues Include:• Mechanism of V(D)J rearrangement • Commitment to CD4 and CD8 lineages • Mechanisms of T cell help • Lessons from the LPR mouse • Phosphatidylinositol... molecules in T-cell activation
  • Biochimica et Biophysica Acta: Molecular Basis of Disease

    • ISSN: 0925-4439
    BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights. Topics of interest include, but are not limited toAgingCancerCardiov... diseasesCell death–related diseasesGenetic diseasesGenetic and epigenetic regulation in diseasesImmunologica... diseasesInflammatory diseasesMetabolic diseasesMitochondria... diseasesMuscular diseasesNeurological diseasesThe non-preferred topics for BBADIS includeNon-coding RNAsResearch on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.Single Cell Line StudiesStudies involving single cell lines will be considered only if they present significantly novel findings.Computation... (in Silico) StudiesPurely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.Disease BiomarkersResearch on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.Descripti... or Correlative StudiesDescriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.Natural Products and Traditional MedicineWork on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.Clinical Studies and Case ReportsClinical studies or case reports without mechanistic insights are outside the scope of the journal.Hypothesis ArticlesSubmissions based solely on hypotheses will not be considered.Comparati... Genomics StudiesComparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.Incremental WorkResearch that offers incremental advancements without significant novelty or impact will generally be declined.
  • The Lancet

    • ISSN: 0140-6736
    The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people.The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues, and Online First content, we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health.
  • Human Immunology

    • ISSN: 0198-8859
    Human Immunology publishes full-length, original, hypothesis-driven basic and clinical research articles as well as brief communications, reviews and editorials covering immunogenetics, transplantation immunology, autoimmunity, and immunity to infectious diseases in humans. It also publishes short population reports, which are tied to the allelefrequencies.ne... database, describing allele frequencies of HLA and KIR.The journal's scope includes understanding the genetic and functional mechanisms that distinguish human individuals in their immune responses to allografts, pregnancy, infections or vaccines as well as the immune responses that lead to autoimmunity, allergy or drug hypersensitivity. It also includes examining the distribution of the genes controlling these responses in populations.Research areas include: • Studies of the genetics, genomics, polymorphism, evolution, and population distribution of immune-related genes • Studies of the expression, structure and function of the products of immune-related genes • Immunogenetics of susceptibility to infectious and autoimmune disease, and allergy • The role of the immune-related genes in hematopoietic stem cell, solid organ, and vascularized composite allograft transplant • Histocompatibility studies including alloantibodies, epitope definition, and T cell alloreactivity • Studies of immunologic tolerance and pregnancy • T cell, B cell, NK and regulatory cell functions, particularly related to subjects within the journal's scope • Pharmacogenomics and vaccine development in the context of immune-related genesHuman Immunology considers immune-related genes to include those encoding classical and non-classical HLA, KIR, MIC, minor histocompatibility antigens (mHAg), immunoglobulins, TCR, BCR, proteins involved in antigen processing and presentation, complement, Fc receptors, chemokines and cytokines. Other immune-related genes may be considered.Human Immunology is also interested in bioinformatics of immune-related genes and organizational topics impacting laboratory processes, organ allocation, clinical strategies, and registries related to autoimmunity and transplantation.Orig... papers with new data will be given preference over uninvited reviews and meta-analyses.Origin... papers with new data will be given preference over uninvited reviews and meta-analyses. As the flagship scientific publication of the American Society for Histocompatibility and Immunogenetics (ASHI), Human Immunology is primarily directed to readers with an interest in histocompatibility, immunogenetics, transplantation, anthropology/populat... studies, HLA disease association and pharmacogenomics. These include basic and clinical scientists as well as histocompatibility laboratory professionals.
  • International Journal for Parasitology

    • ISSN: 0020-7519
    Sponsored by the Australian Society for ParasitologyThe International Journal for Parasitology publishes the results of original research in all aspects of basic and applied parasitology, including all the fields covered by its Specialist Editors, and ranging from parasites and host-parasite relationships of intrinsic biological interest to those of social and economic importance in human and veterinary medicine and agriculture. Original research includes the development of novel and innovative concepts and ideas, as well as experimental and observational science that raises new hypotheses.We do not publish new genome sequences and assemblies alone without new and significant insight into the biology of the parasite, the parasite-host relationship or mechanisms of pathogenesis. Because of its breadth of discipline coverage, the aims and significance of all contributions should be made clear to readers who are not expert in the particular subject of papers. In applied parasitology, it will tend to favour contributions of broader significance to the subject rather than narrow, highly specialised applications. The principal form of publication is the full length paper which contains substantial results from a major program of research. The Journal also provides a medium for the publication of shorter, but complete, papers reporting highly significant original findings, as Succinctus articles. It also publishes Thematic Issues incorporating papers on a topical theme and commissions papers with emphasis on shorter, focussed Reviews of topical issues and strategically important subjects. The Journal encourages critical comment and debate on matters of current controversy in parasitology via "Current Opinions".The International Journal for Parasitology has also launched two specialist, open access titles you are welcome to submit to:International Journal for Parasitology: Parasites and WildlifeInternationa... Journal for Parasitology: Drugs and Drug Resistance
  • Journal of Hospital Infection

    • ISSN: 0195-6701
    An Official Journal of the Healthcare Infection SocietyThe Journal of Hospital Infection is the editorially independent scientific publication of the Healthcare Infection Society. The aim of the Journal is to publish high quality research and information relating to infection prevention and control that is relevant to an international audience.The Journal welcomes submissions that relate to all aspects of infection prevention and control in healthcare settings. This includes submissions that:provide new insight into the epidemiology, surveillance, or prevention and control of healthcare-associate... infections and antimicrobial resistance in healthcare settings;provide new insight into cleaning, disinfection and decontamination;prov... new insight into the design of healthcare premises;describe novel aspects of outbreaks of infection;throw light on techniques for effective antimicrobial stewardship;describe novel techniques (laboratory-based or point of care) for the detection of infection or antimicrobial resistance in the healthcare setting, particularly if these can be used to facilitate infection prevention and control;improve understanding of the motivations of safe healthcare behaviour, or describe techniques for achieving behavioural and cultural change;improve understanding of the use of IT systems in infection surveillance and prevention and control.We also welcome submissions that relate to national policies or guidelines, especially where the subject matter is of international relevance.Although our readership is predominantly clinical, we are also pleased to receive basic science submissions that have clinical relevance.The Journal's open access companion title, Infection Prevention in Practice, welcomes a range of submissions providing practical information to healthcare professionals working in infection prevention and control.
  • Microbial Pathogenesis

    • ISSN: 0882-4010
    Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports.Research Areas Include:Pathogenesis... factorsHost susceptibility or resistanceImmune mechanismsIdentifica... cloning and sequencing of relevant genesGenetic studiesViruses, prokaryotic organisms and protozoaMicrobiotaSy... biology related to infectious diseasesTargets for vaccine design (pre-clinical studies)The journal aims for rapid publication of articles of high quality and significance in an international forum. Please note that reviews are only accepted upon editorial invitation.Short Communications have the following limits. The manuscript should ideally contain no more than 4-6 Figures/Tables and 4000 words, including the title page, all sections of the manuscript (including the references), and Figure/Table legends. The abstract should be limited to 200 words.Microbial Pathogenesis does not accept submissions that primarily consist of (a) bioinformatics or computational analysis of public genomic or transcriptomic databases, or (b) the testing and evaluation of previously uncharacterized natural product-based drug candidates. The journal does not publish purely bioinformatic or computational studies without substantial experimental validation. Please be aware that experimental validation is a mandatory requirement for all submissions.
  • Veterinary Immunology and Immunopathology

    • ISSN: 0165-2427
    An International Journal of Comparative ImmunologyThe journal reports basic, comparative and clinical immunology as they pertain to the animal species designated here: livestock, poultry, and fish species that are major food animals and companion animals such as cats, dogs, horses and camels, and wildlife species that act as reservoirs for food, companion or human infectious diseases, or as models for human disease.Rodent models of infectious diseases that are of importance in the animal species indicated above,when the disease requires a level of containment that is not readily available for larger animal experimentation (ABSL3), will be considered. Papers on rabbits, lizards, guinea pigs, badgers, armadillos, elephants, antelope, and buffalo will be reviewed if the research advances our fundamental understanding of immunology, or if they act as a reservoir of infectious disease for the primary animal species designated above, or for humans. Manuscripts employing other species will be reviewed if justified as fitting into the categories above.The following topics are appropriate: biology of cells and mechanisms of the immune system, immunochemistry, immunodeficiencies, immunodiagnosis, immunogenetics, immunopathology, immunology of infectious disease and tumors, immunoprophylaxis including vaccine development and delivery, immunological aspects of pregnancy including passive immunity, autoimmuity, neuroimmunology, and transplanatation immunology. Manuscripts that describe new genes and development of tools such as monoclonal antibodies are also of interest when part of a larger biological study. Studies employing extracts or constituents (plant extracts, feed additives or microbiome) must be sufficiently defined to be reproduced in other laboratories and also provide evidence for possible mechanisms and not simply show an effect on the immune system.Ideas and suggestions for Special Issues are also welcome. These may focus on a planned conference/symposium for which a selection of the best papers could be published together (after peer review). Alternatively, they could consist of a group of invited papers which together present an up-to-date overview on an important immunological topic.
  • Clinical Microbiology Newsletter

    • ISSN: 0196-4399
    Clinical Microbiology Newsletter is published four issues per year to provide consistent educational features and to keep pace with advances in the fast-moving field of Clinical Microbiology.Clinica... Microbiology Newsletter aims to provide articles to enable you to streamline procedures and improve results. It publishes reviews on infectious disease pathogens, reports on changes that affect your work, including articles on new diagnostic techniques, regulatory and guideline changes, and challenging diagnostic dogmas, clinical cases focused on diagnostic approaches for both common and uncommon pathogens.The journal publishes three types of articles:Mini-review... Case presentationsSnapsho... articles cover topics including:Minireview... on the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of infectious diseases,Practical articles on common and contemporary laboratory techniques,Indispens... updates on important clinical problems that impact the clinical laboratory,Editorial... and opinions on controversial issues in laboratory medicine,Case-based articles focused on diagnostic approaches for infectious pathogens,Snapshots highlighting specific infectious pathogens, therapeutic options, and diagnostic methodologies.Helpfu... tips on improving the laboratory workplace.
  • Transplantation Proceedings

    • ISSN: 0041-1345
    Transplantation Proceedings publishes different categories of manuscripts, all of which undergo extensive peer review by recognized authorities in the field. A type of manuscript consists of emerging scientific advances from affiliated transplantation societies' congresses, conferences, and symposia. Another category provides in-depth original basic and clinical research articles on transplantation.To provide a forum for scientific advancements in;All aspects of solid organTissueStem cell transplantationInclu... patient careClinical practiceResearchEduc... Publication of Affiliated Societies: Asian Transplantation Society; Andalusian Transplantation Society; Brazilian Transplantation Society; Hellenic Transplantation Society; Hungarian Transplantation Society; International Society of Organ Donation and Procurement; Italian Transplantation Society; Japan/Korea Transplantation Society Forum; Latin America and the Caribbean Transplantation Society; Luso-Brazilian Congresses; Polish Transplantation Society; Portuguese Transplantation Society; Spanish Transplantation Society; Turkish Transplantation Centers Coordinators Association.Original basic or clinical science articles, clinical trials and case studies can be submitted to the journals open access companion title Transplantation Reports.
  • The Journal of Heart and Lung Transplantation

    • ISSN: 1053-2498
    The Journal of Heart and Lung Transplantation (JHLT), the official publication of the International Society for Heart and Lung Transplantation, brings readers cutting-edge clinical, basic, and translational science in the fields of advanced heart and lung disease, cardio-pulmonary transplantation, mechanical and biological support of the failing heart, pulmonary vascular disease (pulmonary arterial hypertension and CTEPH), extracorporeal support of donor organs, and cell replacement therapy.
  • European Journal of Internal Medicine

    • ISSN: 0953-6205
    European Journal of Internal Medicine is the official journal of the European Federation of Internal Medicine (EFIM) and is the reference scientific journal for the European academic and non-academic internists. European Journal of Internal Medicine  is devoted to promoting science and practice in internal medicine in Europe. To this end, the journal publishes original articles, editorials, reviews, internal medicine flashcards, and other information relevant to internal medicine and related fields. Translational medicine and clinical studies both receive attention by the Journal. EJIM has the ambition to become the place for the publication of excellent clinical studies; however, this target is intended to be associated with the improvement of the quality of health care in Internal Medicine in the European hospitals.The journal encourages the submission, as original articles, of: quality clinical studies related to internal medicine;papers defining the unmet clinical needs in several areas of internal medicine;methodology of clinical research and critical reading of clinical studies;high-level subgroup or secondary analyses of the major clinical trials;experimental design of planned or ongoing large clinical trials. This publication may be associated with a critical assessment by methodology experts commenting the methodology of the paper, strengths and potential limitations;acute and critical care medicine as well as emergency medicine to contribute to develop the new professional figure of the internist in the European hospitals;In addition to the abovementioned articles, the journal publishes invited articles on clinical issues relevant to internal medicine, in the form of: Commentary: a paper commenting an article published in a particular issue and prepared by the Editors or by an invited expert;Editorial: a brief article on clinical achievements or debated points in Internal Medicine;Review Articles: updated state-of-the-art reviews on a subject of clinical relevance;Ideas and Opinions: a paper on a vision concerning a clinical topic not necessarily reflecting evidence-based data but more an expression of a particular vision of a clinical or public health issue;Clinical Controversies in Internal Medicine, covering pros and cons positions on a specific clinical issue;Clinical Insights: a brief article dedicated to the management of particular clinical situation or setting where remarkable advancements or changes in clinical practice were recently experienced;Beyond the Guidelines on clinical situations or issues that are not covered by the Guidelines or on the limitations of the Guidelines. More in general, this type of articles can be a commentary on recently published guidelines.
  • International Journal of Antimicrobial Agents

    • ISSN: 0924-8579
    Official journal of the International Society of Antimicrobial ChemotherapyThe International Journal of Antimicrobial Agents provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents (antiviral agents, antiparasitic agents, antibacterial agents, antifungal agents, etc.). In addition, the journal signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents. Special attention is given to articles providing insight into the problems of antimicrobial resistance both in the hospital and in the community. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.Additional information on the ISAC and its activities can be found at the ISAC Web site at: https://www.isac.wor...
  • Oral Oncology

    • ISSN: 1368-8375
    A Journal Related to Head & Neck OncologyOral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck.Oral Oncology is of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngolog... plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields.Basic, translational, or clinical Research or Review papers of high quality and that make a contribution to new knowledge are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue, oral cavity, oropharynx, salivary glands, sinuses, nose, nasopharynx, larynx, skull base, thyroid, and craniofacial region, and the related hard and soft tissues and lymph nodes):• Etiopathogenesis: natural history of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic changes; cellular and molecular changes; microorganisms; growth factors, adhesion and other molecules • Epidemiology; risk factors; biomarkers; protective factors; geographic factors; prevention; screening and intervention • Clinical features; orofacial effects of neoplasms at both local and distant sites; tumor staging and grading • Diagnosis; detection of cancer and pre-cancer; cellular and molecular markers for diagnosis; advances in imaging and other functional diagnostic modalities for cancer and pre-cancer • Management and Prognosis; clinical, cellular and molecular markers for prognosis; treatment options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms of surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics (new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and oral health care. • Quality of life issues; issues of consent; psychosocial aspects; patient and health professional information; patient involvement; psychological interventions, improving outcomes; the prevention, diagnosis and management of complications, including, pain, hemorrhage, dysfunction, deformity, osteoradionecrosis, xerostomia, and others; rehabilitation; palliative and end of life care; and support teamwork.
  • Acta Tropica

    • ISSN: 0001-706X
    Acta Tropica is an international journal on infectious diseases that covers public health sciences, medical and veterinary entomology, and biomedical research with particular emphasis on topics relevant to human and animal health.Its scope includes the biology of pathogens and vectors, host-parasite relationships, mechanisms of pathogenicity, clinical disease and chemotherapy. We welcome contributions in basic or applied research in disciplines such as epidemiology, disease ecology, diagnostics, interventions and control, drug and insecticide resistance, mathematical modelling, public health and social sciences, climate change, parasite and vector taxonomy, biology, ecology and behaviour, host and parasite genomics, biochemistry, immunology, and vaccine testing.Contribution... may be in the form of original research papers, review articles, short communications, opinion articles, or letters to the Editors.Only manuscripts of high scientific significance and innovation will be considered for publication. Criteria for rejection without review:Out of scopeManuscripts of minimal international relevance, including regional reports and studies of local interestCase reportsParasite and vector control strategies at very early inconclusive laboratory stages of development. For vector control studies, field validation is requiredField studies not replicated at least over two yearsStudies dealing with natural products (e.g., plant extracts) not characterized from a chemical point of view.Ethical issues, including plagiarism, submission of the manuscript to multiple journals, and lack of ethical approval where needed.Important Guidelines for AcceptanceEditors and the Editorial Board of Acta Tropica provide the following guidelines to help authors prepare manuscripts of high quality that can be considered for publication. Maximize your chances of acceptance by making sure your manuscript:Matches the scientific scope of the journalFollows the instructions specified in Acta Tropica guide for authorsPresents results that significantly advance science including innovative new approachesMeets quality standards of presentation and literature citationDemonstrates potential health or biomedical impact.The above points are critical for the publication of original papers. Be aware Editors carefully evaluate initial manuscript submissions and only those meeting the above criteria will be forwarded to review. If reviewed favourably and the authors seriously address all concerns, then chances of acceptance are increased. Review and Opinion articles may be invited by the Editors in Chief or submitted by authors responding to a recognized need. Reviews are expected to carefully synthesize and discuss the literature and make recommendations to advance respective scientific fields. Reviews and Opinions submitted by authors without research experience on the topic covered by the manuscript will not be considered. Systematic reviews adhering to PRISMA guidelines and meta-analyses are welcome. For any inquiry about Reviews and Opinions please contact our Special Content Editor, Prof. John Beier.
  • Transplant Immunology

    • ISSN: 0966-3274
    Transplant Immunology will publish up-to-date information on all aspects of the broad field it encompasses. The journal is directed to general scientific and medical audience but in particular to basic and applied scientists, transplant-related laboratory personnel, transplant physicians and surgeons. The journal will present research reports and clinical data on all immunological aspects of organ-, tissue-, and haematopoietic stem cell transplantation. Furthermore, the journal is interested to publish high quality basic and clinical research in immunology, physiology and pathophysiology related to processes and diseases affecting transplant patients. Original papers, Brief reports, Cases reports and Review articles and Hypotheses will be considered for publication. Submitted manuscripts will be rapidly peer-reviewed and published. They will be judged on the basis of scientific merit, originality, timeliness and quality.
  • Antiviral Research

    • ISSN: 0166-3542
    Antiviral Research aims to publish manuscripts in the field of prevention and treatment of viral diseases in humans and vertebrate animals, and encourages authors to the submit manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases. The journal is an Official Publication of the International Society for Antiviral Research. The types of papers published in Antiviral Research includes original research reports, short communications, commentaries and invited review* articles on the control of viral infections in humans. The journal’s scope encompasses:antivira... drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action.identificatio... and validation of new drug targets;laboratory animal models of viral diseases for antiviral efficacy testing;evolution of drug-resistant viruses and the development of effective counter measures;pathogenesi... of viral diseases and mechanisms of viral evasion of host immune responses;assessment... of drug safety;new or improved vaccines against viral infections of humans; the prevention and treatment of viral diseases of vertebrate animals, and reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis that must be clearly described in the manuscript.Antiviral Research journal does not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species.We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We discourage the submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]."ISAR members Authors who are ISAR members are encouraged to contact ISAR after their paper has been accepted for publication in order to benefit from their published work being highlighted in ISAR postings on their social media platforms (further details on this will be given in the AVR acceptance letter). *Antiviral Research journal has started a new initiative to publish at least two thematic special issues per year, containing invited reviews in addition to the ad hoc invitations to experts in the areas within the scope of the journal.
  • Tuberculosis

    • ISSN: 1472-9792
    Tuberculosis is a speciality journal focusing on basic experimental research on tuberculosis.Tubercu... aims to publish original research and reviews. It publishes articles on host response and immunology of tuberculosis and the molecular biology, genetics and physiology of the organism.Submissions on bacteriological, immunological and pathogenesis aspects of the disease are particularly welcomed.The journal publishes topics including:• Clinical Trials • Diagnostics • Antimicrobial resistance • Immunology • Leprosy • Microbiology, including microbial physiology • Molecular epidemiology • Non-tuberculous Mycobacteria • Pathogenesis & Pathology • Vaccine developmentPlease note Tuberculosis does not consider:submissions with a meta-analytical focus (e.g., articles based on searches of published articles in public electronic databases will not be considered, especially where there is lack of evidence of the personal involvement of authors in the generation of such material). articles reporting the reanalysis of published data sets to generate hypotheses where there is lack of evidence of the personal involvement of authors in the generation of such material, and where no attempt has been made to test hypotheses experimentally will not be considered.case report submissions or clinical case studies. Submit manuscripts of this type to the companion journals IDCases and Clinical Microbiology Newsletter.articles reporting in silico drug discovery and molecular modelling will not be considered without experimental work to demonstrate meaningful insight into the activity of the series under investigation; further biological evaluation of the mechanism of action, cytotoxicity and potential for drug development is encouraged.Review articles that do NOT offer novel perspectives or insight into a topic and are NOT of general interest to the readership of the journal, or have been covered recently elsewhere, will not be considered.
  • Diagnostic Microbiology and Infectious Disease

    • ISSN: 0732-8893
    Diagnostic Microbiology and Infectious Disease provides up to date and extensive articles on clinical microbiology.Diagnos... Microbiology and Infectious Disease aims to publish latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. It publishes articles on studies in bacteriology, virology, mycology, parasitology, immunology related to infections, immunoserology.Submi... on new procedures, unusual cases, controversial issues, and important new literature. are particularly welcomed.The journal publishes topics including:Informed commentaries on new antibioticsRapid and cost-effective methods in the laboratoryInstructiv... case studies with emphasis on complex circumstancesInsight... editorials on important current issuesBook reviews that keep you up-to-date on recently published literatureLaboratory and clinical management of microbial diseasesEpidemiology and pathogenesis of infectionsAutomation in the diagnostic microbiology laboratoryAntibiotic susceptibility testing
  • Comparative Immunology, Microbiology & Infectious Diseases

    • ISSN: 0147-9571
    An International Journal focused on Comparative Veterinary and Medical ResearchComparative Immunology, Microbiology & Infectious Diseases aims to respond to the concept of "One Medicine - One Health" and to provide a venue for scientific exchange. Based on the concept of "Comparative Medicine" interdisciplinary cooperation between specialists in human and animal medicine is of mutual interest and benefit. Therefore, there is need to combine the respective interest of physicians, veterinarians and other health professionals for comparative studies relevant to either human or animal medicine .CIMID is mainly focusing on applied veterinary medicine with a particular focus on zoonotic pathogens. It includes etiology, biology, clinical diseases, epidemiology, diagnosis, control. Experimental in vitro studies and studies on laboratory animals are generally not accepted. Non infectious diseases are not accepted. Specific focus on human diseases can only be accepted if it concerns major zoonotic pathogens. Reviews are generally not accepted, except if they contain new or recent developments. CIMID does not accept manuscript focusing on Mycology.The journal is open to subjects of common interest related to the immunology, immunopathology, microbiology, parasitology and epidemiology of human and animal infectious diseases, especially zoonotic infections, and animal models of human infectious diseases. The role of environmental factors in disease emergence is emphasized. CIMID is mainly focusing on applied veterinary and human medicine rather than on fundamental experimental research.Original research papers of high quality and novelty on aspects of host response, molecular biology, pathogenesis, control and prevention and treatment of microbial and parasitic diseases of domestic animals and wildlife (if the infections are of zoonotic interest and/or in relation with domestic animals and/or can serve as a model for human diseases). Papers dealing primarily with epidemiology will be considered if they demonstrate a clear impact on the clinical features, pathogenesis or prevention of a disease. Similarly, articles addressing microbiology, parasitology, immunology or pathogenesis must address issues of comparative medical interest. Manuscripts focusing on probiotics or diseases and/or immunology of fishes are not part of our overall scope, as they are better fitted to more specialized journals. Manuscripts dealing with food hygiene and food risk are not part of our overall scope. Manuscripts dealing strictly with experimental design and fundamental research may not be considered depending the overall consequences for the knowledge of a disease.Review articles can be accepted. They should focus either on a pathogen or on analyses of the mechanisms of host-pathogen interactions including epidemiological studies. Proposal for such manuscripts should be submitted to the Co-Editors in Chief for approval before submitting the manuscript.Papers focusing solely on diagnostic techniques, case reports or drug trials will generally not be accepted. Papers of geographically limited interest, which repeat what had been established elsewhere, will not be considered. The readership of the journal is global. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.Papers will be rejected if standards of care of, or procedures performed on animals are not beyond those expected of humane veterinary care. Standards must, at least, meet the International Guiding Principles for Biomedical Research involving Animals, as issued by the Council for International Organizations of Medical Sciences. (C.I.O.M.S., c/o WHO, CH 1211 Geneva 27, Switzerland).Instruc... for Authors:Comparative Immunology, Microbiology & Infectious Diseases consists of six issues a year and publishes original papers or reviews of the status of current research relative to the different fields of Immunology, Microbiology and Infectious Diseases of animals with a possible impact on human health.Immunology: manuscripts are accepted relative to the various branches of this discipline: fundamental Immunology, experimental or comparative Immunology, clinical Immunology, Immunopathology.Micr... manuscripts are accepted relative to the various branches of this discipline: Virology, Bacteriology, Parasitology.Infecti... Diseases: manuscripts are accepted relative to the various branches: Etiology, Pathogenesis, Diagnosis, Prophylaxis, Treatment, Epidemiology, Epizootiology of infectious diseases of animals with a particular interest on zoonoses and one health.
  • Journal of Neuroimmunology

    • ISSN: 0165-5728
    The Journal of Neuroimmunology affords a forum for the publication of works on all branches of the neurosciences with the scope of uncovering aspects of neuro-immune interactions. Specific areas of interest are related (but not exclusive) to neuroinflammatory, neurodegenerative, neuroinfectious, and psychiatric diseases, peripheral neuropathies, spinal cord injury, neuroimaging, studies on central nervous systems (CNS) barriers and lymphatics, brain cancer, role of innate and adaptive immunity, immunometabolism and metabolic regulation of neuro-immune responses, and the gut microbiome in CNS health and diseases.The scope of the Journal is broad, covering both research and clinical problems of neuroscientific interest giving priorities to cutting edge and novel work.A major aim of the Journal is to encourage the development of approaches to analyze in depth the neuroimmune system and interactions between neurons, glial, and immune cells.
  • International Immunopharmacology

    • ISSN: 1567-5769
    International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.Internationa... Immunopharmacology does not accept submissions that consist primarily of bioinformatics or computational analyses of public genomic or transcriptomic databases, unless they are supported by experimental studies involving cells, organoids, or experimental animals.Internationa... Immunopharmacology no longer accept manuscripts consisting solely of meta-analyses, bibliometric studies, or statistical analyses of publicly available datasets.The subject material appropriate for submission includes: • Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders. • Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses. • Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action. • Agents that activate genes or modify transcription and translation within the immune response. • Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active. • Production, function and regulation of cytokines and their receptors. • Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions. • Studies on the nature and function of drug and hormone receptors on lymphocytes and other cells in the immune system.• Studies of cell-derived or humoral factors that modify the immune system causing cytotoxicity, inducing antibody production and mediating inflammatory responses. • The development of immunologically based assays and their application to disease, including assays for drugs, hormones, cyclic nucleotides, tumor antigens, etc.
  • Journal of Autoimmunity

    • ISSN: 0896-8411
    The Journal of Autoimmunity is a parent journal of the Journal of Translational Autoimmunity . The Journal of Autoimmunity publishes papers related to the diverse aspects of autoimmunity: the mechanism of self-recognition, regulation of autoimmune responses, experimental autoimmune diseases, diagnostic autoantibody tests, and the epidemiology, pathophysiology, and treatment of autoimmune diseases. Special, but not exclusive, attention will be given to papers dealing with genetic, molecular biology, and cellular aspects of the discipline.Research Areas Include:• Underlying mechanisms of autoimmunity • Immunologic • Molecular • Cellular • Genetic • VirologicAreas of Clinical Interest:• Rheumatology • Dermatology • Endocrinology • Nephrology • Haematology • Immunopharmacology
  • Autoimmunity Reviews

    • ISSN: 1568-9972
    Autoimmunity Reviews will publish up-to-date, structured reviews on diverse topics in autoimmunity, written by first-class experts in the field. The articles will include demonstrative illustrations and tables and will all have a "take-home" message.Articles will principally be invited by the Editors-in-Chief upon the recommendations of the international Editorial Board, and will cover all fields of autoimmunology, bridging the gap between basic and clinical sciences. Contributions in basic sciences will include those on the pathophysiology and mechanisms of disorders as well as genomics and proteomics; clinical contributions will focus upon the diseases, novel therapies and clinical associations.